Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy.
The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others. The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.North America is the largest consumption place, with a consumption market share nearly 51% in 2017; Europe is the second largest consumption place with the consumption market share of 21% in 2017. Market competition is not intense. Mundipharma, Mylan, Qilu Pharma, Tesaro, Eisai, Novartis etc. are the leaders of the industry with the market share are about 66% in 2017.
The report details the trend, potential and market size of Chemotherapy-induced Nausea and Vomiting Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chemotherapy-induced Nausea and Vomiting Drugsmarket, defines the market attractiveness level of Chemotherapy-induced Nausea and Vomiting Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chemotherapy-induced Nausea and Vomiting Drugs industry, describes the types of Chemotherapy-induced Nausea and Vomiting Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chemotherapy-induced Nausea and Vomiting Drugs market and the development prospects and opportunities of Chemotherapy-induced Nausea and Vomiting Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chemotherapy-induced Nausea and Vomiting Drugs market in Chapter 13.
By Player:
Mundipharma
Mylan
Qilu Pharma
Tesaro
Eisai
Novartis
Teva
Heron Therapeutics
Merck
Roche
By Type:
5-HT3 Inhibitors
NK1 Inhibitors
Other
By End-User:
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chemotherapy-induced Nausea and Vomiting Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chemotherapy-induced Nausea and Vomiting Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chemotherapy-induced Nausea and Vomiting Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Outlook to 2022
-
7.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.2 United States Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.4 China Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.5 Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.6 India Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
-
7.7 South Korea Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2017-2022)
8 Region and Country-wise Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis and Outlook to 2028
-
8.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.2 United States Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.4 China Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.6 India Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2022-2028)
9 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 5-HT3 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global NK1 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Highly Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Moderately Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Low Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 5-HT3 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global NK1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Highly Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Moderately Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Low Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Chemotherapy-induced Nausea and Vomiting Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Competitive Analysis
-
14.1 Mundipharma
-
14.1.1 Mundipharma Company Details
-
14.1.2 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.2 Mylan
-
14.2.1 Mylan Company Details
-
14.2.2 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.3 Qilu Pharma
-
14.3.1 Qilu Pharma Company Details
-
14.3.2 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.4 Tesaro
-
14.4.1 Tesaro Company Details
-
14.4.2 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.5 Eisai
-
14.5.1 Eisai Company Details
-
14.5.2 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.7 Teva
-
14.7.1 Teva Company Details
-
14.7.2 Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.8 Heron Therapeutics
-
14.8.1 Heron Therapeutics Company Details
-
14.8.2 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
14.10 Roche
-
14.10.1 Roche Company Details
-
14.10.2 Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chemotherapy-induced Nausea and Vomiting Drugs
-
Figure Chemotherapy-induced Nausea and Vomiting Drugs Picture
-
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Country (2017-2022)
-
Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chemotherapy-induced Nausea and Vomiting Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5-HT3 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global NK1 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Highly Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Moderately Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Low Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 5-HT3 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NK1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Highly Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderately Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Low Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Mundipharma (Foundation Year, Company Profile and etc.)
-
Table Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Qilu Pharma (Foundation Year, Company Profile and etc.)
-
Table Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Tesaro (Foundation Year, Company Profile and etc.)
-
Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Heron Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Chemotherapy-induced Nausea and Vomiting Drugs Product and Service
-
